Methods of Treating Psychiatric or Neurological Disorders with MGLUR Antagonists

Methods for treating a psychiatric or neurological disease or disorder using combinations of Group 1 mGluR antagonists are disclosed. In certain aspects, these methods include the treatment of a patient having a neurological or psychiatric disease or disorder associated with a CYFIP1 gene change.

Saved in:
Bibliographic Details
Main Authors SAKURAI TAKESHI, BUXBAUM JOSEPH, (BOZDAGI) GUNAL OZLEM
Format Patent
LanguageEnglish
Published 29.08.2013
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Methods for treating a psychiatric or neurological disease or disorder using combinations of Group 1 mGluR antagonists are disclosed. In certain aspects, these methods include the treatment of a patient having a neurological or psychiatric disease or disorder associated with a CYFIP1 gene change.
Bibliography:Application Number: US201013504847